We are removing GALP from our ODDO BHF European Large Caps list. The stock has chalked up a performance of +31.3% since its inclusion in the list on 20 March. Our analyst is adopting today a Neutral recommendation (vs Outperform) on the stock. - ...
>Organic growth low but ahead of expectations - Worldline reported its Q1 2024 revenues. Organic growth was weak at +2.5%, but above expectations (ODDO BHF / consensus = +1.2/+0.7%) and marks an improvement on the low point of Q4 2023 (+1.3%).Merchant Services turned out to be stronger than expected (+3.9%, of which +6.5% excluding planned merchant termination- Q4 2023 reminder = +3.2%) thanks to good results in new markets (such as Italy). Unsurprisingly, Financ...
>Croissance organique faible au T1 mais au-dessus des attentes - Worldline vient de publier son CA au titre du T1 2024. Il fait ressortir une croissance organique faible à +2.5% mais au-dessus des attentes (ODDO BHF / consensus = +1.2/+0.7%) et en amélioration par rapport au point bas du T4 2023 (+1.3%).Les Services aux Commerçants s’avèrent plus dynamique que prévu (+3.9% dont +6.5% hors arrêt planifié de commerçants – rappel T4 2023 = +3.2%) grâce à de bons rés...
WORLDLINE : Q1 2024 revenue Q1 2024 revenueQ1 2024 Group revenue: € 1,097 million +2.5% organically +3.9% in Merchant Services Transformation initiatives on trackRedesign of Merchant Services operating model with two new go-to-market channelsPower24 transformation plan in motion and rolled-out in targeted countries Launch of Crédit Agricole and Worldline joint-venture Unconditional approval received from the European Commission in MarchJV to operate under new brand CAWL, providing innovative payment services to all merchants in France Governance updateWilfried Verstraete coopted as futu...
WORLDLINE: 2023 Universal Registration Document available 2023 Universal Registration Document available Paris La Défense, April 30, 2024 – Worldline [Euronext: WLN], a global leader in payments services, today announces the filing of its 2023 Universal Registration Document with the French Financial Markets Authority (AMF) in ESEF format (European Single Electronic Format) in French version on Tuesday, April 30, 2024, under number D.24-0377. The Universal Registration Document is available to the public in accordance with the applicable regulations and may be consulted on the Company’s w...
WORLDLINE : Mise à disposition du Document d’Enregistrement Universel 2023 Mise à disposition duDocument d’Enregistrement Universel 2023 Paris La Défense, le 30 avril 2024 – Worldline [Euronext : WLN], un leader mondial des paiements, annonce que son Document d’Enregistrement Universel 2023 a été déposé auprès de l’Autorité des marchés financiers (AMF) au format ESEF (European Single Electronic Format) le mardi 30 avril 2024, sous le numéro D.24-0377. Le Document d’Enregistrement Universel est tenu à la disposition du public dans les conditions prévues par la réglementation en vigueur et ...
PARIS & BOSTON--(BUSINESS WIRE)-- Regulatory News: Mauna Kea Technologies (Euronext Growth : ALMKT) (Paris:ALMKT), inventeur de Cellvizio®, la plateforme multidisciplinaire d'endomicroscopie confocale laser par minisonde et par aiguille (p/nCLE), annonce avoir mis à la disposition du public et déposé auprès de l’Autorité des Marchés Financiers (AMF) le 30 avril 2024 son Rapport Financier Annuel relatif à l’exercice clos le 31 décembre 2023. Ce rapport peut être consulté sur le site Internet de Mauna Kea Technologies, dans les conditions prévues par la réglementation en vigueur. Il peut êtr...
Nicklaus Children’s Health System, Philips to provide innovative patient and staff experience, helping to enhance outcomes for the smallest of patients April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence Amsterdam, the Netherlands, and Miami, US – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Nicklaus Children’s Health System, a nationally recognized leader in pediatric care, today announced a 10-year long-term strategic collabora...
At its 1Q24 update Philips surprised the market with a personal injury settlement which has been made much sooner than expected and, at €1bn, is a much lower cost than the €3bn we had in our model. We believe this is a major positive for the investment case. We increase our target price from €19 to €25. We stick to our HOLD rating as: (1) current trading conditions are mixed; and (2) valuation is now fair compared to peers.
Claire McDonald is appointed CEO of SCOR Business Solutions and member of SCOR’s Executive Committee Press release29 April 2024 - N° 06 Claire McDonald is appointed CEO of SCOR Business Solutions and member of SCOR’s Executive Committee Claire McDonald joins SCOR as CEO of SCOR Business Solutions (SBS), the company’s large corporate risks insurance unit, previously named SCOR Specialty Insurance. She will also serve as a member of the Executive Committee. Claire will be responsible for affirming SBS’s position as a technical Specialty Commercial Insurer, focusing on building a bala...
Claire McDonald est nommée Directrice générale de SCOR Business Solutions et membre du Comité exécutif de SCOR Communiqué de presse29 avril 2024 - N° 06 Claire McDonald est nommée Directrice générale de SCOR Business Solutions et membre du Comité exécutif de SCOR Claire McDonald rejoint SCOR en qualité de Directrice générale de SCOR Business Solutions (SBS), l’unité du Groupe consacrée aux grands risques d’entreprise qui était auparavant dénommée SCOR Specialty Insurance (Assurance de spécialités). Claire sera également membre du Comité exécutif. Elle sera chargée d’asseoir la posi...
PARIS & BOSTON--(BUSINESS WIRE)-- Regulatory News: Mauna Kea Technologies (Euronext Growth : ALMKT) (Paris:ALMKT) inventeur de Cellvizio®, la plateforme multidisciplinaire d'endomicroscopie confocale laser par minisonde et par aiguille (p/nCLE), annonce aujourd’hui l'ouverture d’un centre d'excellence français pour l'utilisation du Cellvizio dans le diagnostic du cancer du poumon. La procédure Cellvizio est désormais réalisée en préopératoire par le Professeur Stéphane Renaud, MD, PhD, chirurgien thoracique de référence au Centre Hospitalier Régional Universitaire (CHRU) de Nancy, France. Ce...
>Underlying 1Q24 results in line with consensus estimates - The underlying 1Q24 results where in line with company compiled consensus estimates. Revenues came in at €4.1bn (vs €4.1bn expected) and Adj EBITA came in at €387mln which is 7% ahead of consensus at €361mln. However if we exclude the beat in the Other segment, we note that the beat on Adjusted EBITA is 1.6%. On a divisional level we see that profitability in Diagnosis & Treatment slightly disappointed (miss ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.